Integra LifeSciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IART and other ETFs, options, and stocks.

About IART

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. 

CEO
Stuart M. Essig
CEOStuart M. Essig
Employees
4,427
Employees4,427
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1989
Founded1989
Employees
4,427
Employees4,427

IART Key Statistics

Market cap
1.04B
Market cap1.04B
Price-Earnings ratio
-141.62
Price-Earnings ratio-141.62
Dividend yield
—
Dividend yield—
Average volume
1.29M
Average volume1.29M
High today
$13.86
High today$13.86
Low today
$13.24
Low today$13.24
Open price
$13.42
Open price$13.42
Volume
1.23M
Volume1.23M
52 Week high
$20.49
52 Week high$20.49
52 Week low
$8.70
52 Week low$8.70

Stock Snapshot

Integra LifeSciences(IART) stock is priced at $13.44, giving the company a market capitalization of 1.04B. It carries a P/E multiple of -141.62.

During the trading session on 2026-10-10, Integra LifeSciences(IART) shares reached a daily high of $13.86 and a low of $13.24. At a current price of $13.44, the stock is +1.5% higher than the low and still -3.0% under the high.

Trading volume for Integra LifeSciences(IART) stock has reached 1.23M, versus its average volume of 1.29M.

The stock's 52-week range extends from a low of $8.70 to a high of $20.49.

The stock's 52-week range extends from a low of $8.70 to a high of $20.49.

IART News

TipRanks 1d
Integra LifeSciences Prices $450 Million Senior Notes

Integra Lifesciences ( (IART) ) just unveiled an announcement. On October 9, 2026, Integra LifeSciences announced it had priced $450 million of senior secured...

Benzinga 5d
Flood Damage Prompts Integra LifeSciences To Revise 2026 Outlook

Integra LifeSciences Holdings Corporation (NASDAQ:IART) shares plunged nearly 20% after the medical technology company on Friday reported preliminary third-quar...

Flood Damage Prompts Integra LifeSciences To Revise 2026 Outlook

Analyst ratings

58%

of 12 ratings
Buy
25%
Hold
58.3%
Sell
16.7%

People also own

Based on the portfolios of people who own IART. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.